Page last updated: 2024-11-02

oxprenolol and Immunoblastic Lymphadenopathy

oxprenolol has been researched along with Immunoblastic Lymphadenopathy in 1 studies

Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.

Immunoblastic Lymphadenopathy: A disorder characterized by proliferation of arborizing small vessels, prominent immunoblastic proliferations and amorphous acidophilic interstitial material. Clinical manifestations include fever, sweats, weight loss, generalized lymphadenopathy and frequently hepatosplenomegaly.

Research Excerpts

ExcerptRelevanceReference
"The association of AILD and myelofibrosis has been rarely encountered and is hereby discussed."1.27Severe pancytopenia due to marked marrow fibrosis associated with angioimmunoblastic lymphadenopathy. ( Ben Arieh, Y; Brenner, B; Green, J; Nagler, A; Rosenbaum, H; Tatarsky, I, 1985)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brenner, B1
Green, J1
Rosenbaum, H1
Ben Arieh, Y1
Nagler, A1
Tatarsky, I1

Other Studies

1 other study available for oxprenolol and Immunoblastic Lymphadenopathy

ArticleYear
Severe pancytopenia due to marked marrow fibrosis associated with angioimmunoblastic lymphadenopathy.
    Acta haematologica, 1985, Volume: 74, Issue:1

    Topics: Angina Pectoris; Humans; Immunoblastic Lymphadenopathy; Oxprenolol; Pancytopenia; Prednisone; Primar

1985